Sie suchten nach: encapsulated (Englisch - Maltesisch)

the active substance is liposome–encapsulated doxorubicin.
is-sustanza attiva hu doxorubicin inkapsulat f’liposomi.

the product consists of lipid encapsulated perflutren microspheres.
il-prodott huwa magħmul minn mikrosferi ta’ perflutren inkapsulati fil-lipidi.

it acts as host rock in which the wastes are encapsulated;
jaġixxi bħala blat li jirċievi li fih l-iskart huwa inkapsulat;

liposome–encapsulated doxorubicin corresponding to 50 mg doxorubicin hydrochloride
doxorubicin inkapsulat f’liposomi, li jikkorrispondi għal 50 mg ta’ doxorubicin hydrochloride

description: pink paper model encapsulated in plastic, two pages.
deskrizzjoni: mudell ta' karta roża miksija bil-plastika, żewġ paġni.

patients may have increased susceptibility to infections, especially with encapsulated bacteria.
il-pazjenti jista’ jkollhom żieda fis-suxxettibbilità għal infezzjonijiet, speċjalment b’batterji inkapsulati.

from 1 january 2019 onwards dental amalgam shall only be used in an encapsulated form.
mill-1 ta’ jannar 2019 ’il quddiem, l-amalgama dentali għandha tintuża biss f’forma inkapsulata.

liposome– encapsulated doxorubicin– citrate complex corresponding to 50 mg doxorubicin hcl.
kumpless ta ’ doxorubicin- citrate enkapsulat f’ liposoma li jikkorispondi għal 50 mg doxorubicin hcl.

this commitment was encapsulated in the eu's own 2002 action plan for the eradication of iuu fishing1.
dan l-impenn kien miġbur fil-pjan ta’ azzjoni 2002 ta’ l-ue stess għall-eliminazzjoni totali tas-sajd iuu1.

in these patients, phospholipid encapsulated microspheres can bypass the lung and directly enter the arterial circulation.
f’dawn il-pazjenti, mikrosferi fosfolipidi inkapsulati jistgħu jaqbżu l-pulmun u jidħlu direttament fiċ-ċirkolazzjoni arterjali.

liposomal-encapsulated compared with conventional doxorubicin was not found more active in doxorubicin resistant cell lines in vitro.
doxorubicin enkapsulat fil-liposomi meta mqabbel ma’ doxorubicin konvenzjonali ma ntweriex li hu aktar attiv f’razzez ta’ ċelluli reżistenti ta’ doxorubicin in vitro.

encapsulated cytarabine concentrations and the counts of the lipid particles in which the cytarabine is encapsulated in depocyte followed a similar distribution pattern.
konċentrazzjonijiet ta ’ cytarabine inkapsulat u l- għadd tal- partikuli tal - lipidi li fihom cytarabine hu inkapsulat f’ depocyte, segwew mod ta ’ distribuzzjoni simili.

once constituted, the liposomal dispersion for infusion containing liposome-encapsulated doxorubicin should be a red orange opaque homogeneous dispersion.
la darba jkun konstitwit, it-tixrid liposomali għall-infużjoni li fih doxorubicin enkapsulat fil-liposoma għandu jkun ta’ tixrid omoġenju opak ta’ lewn ħamrani-oranġjo.

electronic mark on the pastern: a plastic-encapsulated transponder designed to be fixed to the animal’s pastern.
marka elettronika fuq il-pastur: transponder miksi bil-plastik maħsub biex jitwaħħal mal-pastur ta’ l-annimal.

this approach could be encapsulated in a small businesses act, setting out both principles and concrete measures to support smes throughout their life-cycle.
dan il-metodu jista’ jinġabar f’att dwar in-negozji ż-Żgħar, li jistipula kemm il-prinċipji kif ukoll il-miżuri konkreti ta' sostenn għall-smes matul iċ-ċiklu tal-ħajja tagħhom.

aucs of free and encapsulated cytarabine after ventricular injection of depocyte appeared to increase linearly with increasing dose, indicating that the release of cytarabine from depocyte and the pharmacokinetics of cytarabine are linear in human csf.
l-aucs ta’ cytarabine ħieles u inkapsulat wara injezzjoni ventrikulari ta’ depocyte dehru li żdiedu b’mod lineari ma’ żjieda fid-doża, li jindika li l-ħruġ ta’ cytarabine minn depocyte u l-farmakokinetiċità ta’ cytarabine huma lineari fis-csf uman.

in animals, liposome-encapsulated doxorubicin reduced the distribution to heart and gastrointestinal mucosa compared with conventional doxorubicin, while antitumoural efficacy in experimental tumours was maintained.
f’annimali, doxorubicin enkapsulat fil-liposomi naqqas il-firxa fil-mukosa tal-qalb u dik gastro-intestinali, meta mqabbel ma’ doxorubicin konvenzjonali, waqt li l-effikaċja anti-tumorali f’tumuri sperimentali baqgħet sostnuta.

high-activity sealed radioactive sources are containers of encapsulated radioactive material whose activity is above the limit specified in the directive 2003/122/euratom.
is-sorsi ssiġillati ta' attività għolja (hass) huma kontenituri ta' materjal radjuattiv miġbura f'kapsuli li l-attività tagħhom hija aktar mil-limitu speċifikat fid-direttiva 2003/122/euratom.

it also made an important contribution to the long-term convergence process between partner countries and eu higher education standards and practices – most notably encapsulated within the bologna process and the wider he reform agenda.
huwa ta kontribut importanti wkoll lill-proċess ta’ konverġenza fuq medda twila ta’ żmien bejn il-prattiki u l-istandards tal-edukazzjoni għolja tal-pajjiżi msieħba u tal-ue – l-aktar fil-proċess ta’ bologna u l-aġenda usa’ tar-riforma fl-edukazzjoni għolja.

in general however, the plasma levels of total doxorubicin are substantially higher with myocet than with conventional doxorubicin, while the data indicate that peak plasma levels of free (not liposome-encapsulated) doxorubicin are lower with myocet than with conventional doxorubicin.
b’mod ġenerali madankollu, il-livelli totali ta’ doxorubicin fil-plażma huma sostanzjalment ogħla b’ myocet milli b’doxorubicin konvenzjonali, filwaqt li l-informazzjoni tindika li l-livelli l-aktar għolja ta’ doxorubicin liberu (mhux enkapsulat f’ liposomi) fil-plażma huma anqas b’myocet milli f doxorubicin konvenzjonali.